Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Royalindo Investa Wijaya Tbk. (INDO) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Royalindo Investa Wijaya Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Royalindo Investa Wijaya Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Royalindo Investa Wijaya Tbk. trades at Rp184 (market cap 819.98B, 35.04M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Royalindo Investa Wijaya Tbk. is far larger — about 4.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Royalindo Investa Wijaya Tbk. is more actively traded (35.04M versus 324K). Which is the better fit depends on your goals.

INDOOBAT
Market Cap
819.98B166.01B
Volume
35.04M324K
Lot
350.41K3.24K
Turnover
6.39B77.68M
Average Price
182.46239.75
Value
6.39B77.68M
Indicative Equilibrium Price
184240
Indicative Equilibrium Volume
151

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INDO
View details
OBAT
View details

About Royalindo Investa Wijaya Tbk.

PT Royalindo Investa Wijaya Tbk (the Company) was established based on Notarial Deed No. 19 dated July 6, 2005 of Tse Min Suhardi, S.H., a public notary in Jakarta. The Company started its commercial operations in July 6, 2005.

Read more on INDO

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT